Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills — Class II drug recall D-0389-2016
Terminated recall by Nephron Pharmaceuticals Corp., reported 2015-12-09, distributed nationwide. Discoloration
| Recall number | D-0389-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Nephron Pharmaceuticals Corp., Orlando, FL, United States |
| Recall initiated | 2015-08-21 |
| Classified | 2015-11-27 |
| Reported by FDA | 2015-12-09 |
| Terminated | 2017-02-10 |
| Distributed | Nationwide (US) |
| Quantity | 32,490 cartons |
| NDC | 00487-2784-01 |
| Lot numbers | R4016A |
| Expiration dates | 2015-08-31, 2015-12-31 |
Product
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01
Reason for recall
Discoloration
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0389-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.